| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0056e91780958e4aeb1839c5b305a694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36336454987e432567dcd9dbbf3f6c1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a6c74f3106cf1beddc09d2332fb6e04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8dddb184e723ff67f79ad6c6bd29c427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d438724493d5b89040d43d102f9e696 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a76b76ad2547fb4d96d6dec7ac0be8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7a600f739fa80c743eca459dd719318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_040f4c9fce8fd4a1dd5eeba797f46602 |
| publicationDate |
2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013004462-A1 |
| titleOfInvention |
A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof |
| abstract |
A stable complex of tomoxiprole with 2-hydroxypropyl-beta-cyclodextrin with fast dissolution rate and rapid absorption wherein amorphous tomoxiprole forms a complex with 2-hydroxypropyl-beta-cyclodextrin in about equimolecular ratio. The complex shows a remarkably faster dissolution rate and absorption with respect to crystalline tomoxiprole and is particularly suitable for the production of pharmaceutical oral dosage forms, such as tablets and capsules, where rapid onset of therapeutical action is required. A method of manufacture of the complex is also described and claimed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3083234-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020002851-A1 |
| priorityDate |
2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |